Enzolytics

(OTC) ENZC

Current Price$0.00

Market Cap$3.86M

Since IPO (2008)-100%

5 Year-100%

1 Year+14%

1 Month+33%

Enzolytics Financials at a Glance

Market Cap

$3.86M

Revenue (TTM)

$0.00

Net Income (TTM)

-$404.09K

EPS (TTM)

-$0.00

P/E Ratio

-8.00

Dividend

$0.00

Beta (Volatility)

0.11 (Low)

Dividend

$0.00

Beta (Volatility)

0.11 (Low)

Price

$0.00

Volume

16,803,585

Open

$0.00

Price

$0.00

Volume

16,803,585

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

Dividend

$0.00

Beta (Volatility)

0.11 (Low)

Price

$0.00

Volume

16,803,585

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

N/A

ENZC News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Enzolytics

Industry

Biotechnology

Sector

Health Care

CEO

Steven Sharabura

Website

www.enzolytics.com

Headquarters

Plano, TX 75074, US

ENZC Financials

Key Financial Metrics (TTM)

Gross Margin

Operating Margin

Net Income Margin

Return on Equity

Return on Capital

Return on Assets

-0%

Earnings Yield

-12.50%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$3.86M

Shares Outstanding

4.83B

Volume

16.80M

Avg. Volume

13.36M

Financials (TTM)

Gross Profit

-$5.52K

Operating Income

-$82.98K

EBITDA

-$77.46K

Operating Cash Flow

-$563.04K

Capital Expenditure

$0.00

Free Cash Flow

-$563.04K

Cash & ST Invst.

$200.00M

Total Debt

$996.34K

Enzolytics Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2025YOY CHG

Revenue

$0.00

N/A

Gross Profit

-$5.52K

+0.0%

Gross Margin

0.00%

N/A

Market Cap

$3.86M

N/A

Market Cap/Employee

$3.86M

N/A

Employees

N/A

Net Income

-$92.24K

-4973.7%

EBITDA

-$77.46K

-451.0%

Quarterly Fundamentals

Name

Q2 2025YOY CHG

Total Cash

$200.00M

+0.0%

Total Debt

$996.34K

+0.0%

Accounts Receivable

$5.18K

+0.0%

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$996.34K

+0.0%

Return on Assets

-0.18%

N/A

Return on Invested Capital

0.29%

N/A

Free Cash Flow

$114.84M

+28982.7%

Operating Cash Flow

$114.84M

+28982.7%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

VCNXVaccinex, Inc.

VCNXVaccinex, Inc.$1.01-7.34%

CNNACann American Corp.

CNNACann American Corp.$0.00+15.79%

ISCOInternational Stem Cell Corporation

ISCOInternational Stem Cell Corporation$0.17+0.00%

NBCONeon Bloom, Inc.

NBCONeon Bloom, Inc.$0.01+0.00%

BMNDFBiomind Labs Inc.

BMNDFBiomind Labs Inc.$0.12+0.00%

MDGEFMedigene AG

MDGEFMedigene AG$2.59+0.00%

CAIHFChia Tai Enterprises International Limited

CAIHFChia Tai Enterprises International Limited$0.28+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

AALAmerican Airlines Group

AALAmerican Airlines Group$14.98+0.02%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares$13.59+0.04%

TQQQProShares Trust - ProShares UltraPro Qqq

TQQQProShares Trust - ProShares UltraPro Qqq$77.52+0.02%

SQQQProShares Trust - ProShares UltraPro Short Qqq

SQQQProShares Trust - ProShares UltraPro Short Qqq$40.04-0.02%

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF

NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF$5.02-0.00%

SATSEchoStar

SATSEchoStar$114.08-0.11%

MARAMara Holdings

MARAMara Holdings$14.08+0.03%

Questions About ENZC

What is the current price of Enzolytics?

Enzolytics is trading at $0.00 per share.

What is the 52-week range for Enzolytics?

Over the past 52 weeks, Enzolytics has traded between $0.00 and $0.00.

How much debt does Enzolytics have?

As of the most recent reporting period, Enzolytics reported total debt of $996.34K.

How much cash does Enzolytics have on hand?

Enzolytics reported $0.00 in cash and cash equivalents in its most recent financial results.

What is Enzolytics’s dividend yield?

Enzolytics does not currently have a dividend yield.

Enzolytics

Enzolytics Financials at a Glance

ENZC News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Enzolytics

ENZC Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Enzolytics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ENZC

What is the current price of Enzolytics?

What is the 52-week range for Enzolytics?

How much debt does Enzolytics have?

How much cash does Enzolytics have on hand?

What is Enzolytics’s dividend yield?

Premium Investing Services